Abstract:Intermediate filaments are critical regulators of cell responses and organizers of cellular structures. GFAP (glial fibrillary acidic protein) is an intermediate filament protein mainly expressed in astrocytes. GFAP mutations are associated with Alexander disease (AxD), a type of leukodystrophy that causes degeneration of astrocytes and ultimately neurodegeneration. AxD astrocytes display protein aggregation, proteostasis defects and altered organelle homeostasis. We previously showed that expression of GFAP AxD mutants in astrocytes provoked mitochondrial alterations and oxidative stress. Here we have used an astrocytoma cell model to explore the impact of GFAP AxD mutants on the lysosomal degradation pathway. Expression of GFAP AxD mutants in this model elicits marked alterations in lysosomal distribution. Cells expressing the GFAP R239C mutant display defective lysosomal activity and intraluminal acidification. Lysosomes are primary sites of oxidative damage. Moreover, expression of GFAP R239C increases susceptibility of lysosomes to oxidative stress, resulting in a greater loss of lysosomal mass and compromised membrane integrity, as revealed by increased intraluminal recruitment of galectins, with respect to cells expressing GFAP wt. Notably, lysosomes in GFAP R239C expressing cells are also more vulnerable to chemically-induced rupture. Interestingly, lysosomes of cells expressing GFAP wt are able to rapidly recover after removal of the damaging agent. In sharp contrast, recovery of acidic vesicles is severely impaired in cells expressing GFAP R239C, suggesting a defect in lysosomal repair. Taken together, our results show that expression of the GFAP AxD mutant is sufficient to deeply perturb lysosomal distribution, function and repair. These alterations could contribute to proteostasis defects and cellular toxicity in AxD.

The Alexander Disease Protein GFAP Drives Mitochondrial Fission

Deregulation of Mitochondrial Fusion and Fission in Neurodegenerative Diseases

Mitochondria Are Dynamically Transferring Between Human Neural Cells and Alexander Disease-Associated GFAP Mutations Impair the Astrocytic Transfer

Regulation of mitochondrial fission by GIPC-mediated Drp1 retrograde transport

Lysosomal function, resistance to stress and repair are compromised by expression of the Alexander disease GFAP R239C mutant

Tissue and Cellular Rigidity and Mechanosensitive Signaling Activation in Alexander Disease

Glial fibrillary acidic protein is pathologically modified in Alexander disease

Mitochondrial fission controls astrocyte morphogenesis and organization in the cortex

Mitochondrial fission mediated by Drp1-Fis1 pathway and neurodegenerative diseases

Mutations in GFAP Disrupt the Distribution and Function of Organelles in Human Astrocytes

Charcot‐Marie‐Tooth disease‐associated mutants of GDAP1 dissociate its roles in peroxisomal and mitochondrial fission

Structural basis for regulated assembly of the mitochondrial fission GTPase Drp1

Interaction of mitochondrial fission factor with dynamin related protein 1 governs physiological mitochondrial function in vivo

Drp1-Dependent Mitochondrial Fission Plays Critical Roles in Physiological and Pathological Progresses in Mammals

De novo mutations in GFAP cause Alexander disease: clinical features, fMRI and functional analysis

Mitochondrial Fusion Machinery Specifically Involved in Energy Deprivation-Induced Autophagy

Force-induced tail-autotomy mitochondrial fission and biogenesis of matrix-excluded mitochondrial-derived vesicles for quality control

Fluorescence Lifetime Super-Resolution Imaging Unveil the Dynamic Relationship Between Mitochondrial Membrane Potential and Cristae Structure Using the Förster Resonance Energy Transfer Strategy

Structural basis for GTP hydrolysis and conformational change of MFN1 in mediating membrane fusion

Mff oligomerization is required for Drp1 activation and synergy with actin filaments during mitochondrial division

Mitochondria- and ER-associated actin are required for mitochondrial fusion